Cargando…
Molecular subgroups of medulloblastoma: the current consensus
Medulloblastoma, a small blue cell malignancy of the cerebellum, is a major cause of morbidity and mortality in pediatric oncology. Current mechanisms for clinical prognostication and stratification include clinical factors (age, presence of metastases, and extent of resection) as well as histologic...
Autores principales: | Taylor, Michael D., Northcott, Paul A., Korshunov, Andrey, Remke, Marc, Cho, Yoon-Jae, Clifford, Steven C., Eberhart, Charles G., Parsons, D. Williams, Rutkowski, Stefan, Gajjar, Amar, Ellison, David W., Lichter, Peter, Gilbertson, Richard J., Pomeroy, Scott L., Kool, Marcel, Pfister, Stefan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306779/ https://www.ncbi.nlm.nih.gov/pubmed/22134537 http://dx.doi.org/10.1007/s00401-011-0922-z |
Ejemplares similares
-
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
por: Kool, Marcel, et al.
Publicado: (2012) -
Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays
por: Hovestadt, Volker, et al.
Publicado: (2013) -
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
por: Sharma, Tanvi, et al.
Publicado: (2019) -
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants
por: Pajtler, Kristian W., et al.
Publicado: (2016) -
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
por: Northcott, Paul A., et al.
Publicado: (2011)